Streptococcal infections and psychoses? A preliminary inquiry

Neuropsychiatric Disorders and Infection

Volumn , Issue , 2005, Pages 59-65

  Hanson, Daniel R ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 26444435165     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (87)

1. Kraepelin E. Dementia Praecox and Paraphrenia. Edinburgh: E and S Livingston, 1919.
2. Bleuler E. Dementia Praecox or the Group of Schizophrenias. New York: International University Press, 1950.
3. Faust D. The Limits of Scientific Reasoning. Minneapolis: University of Minnesota Press, 1984.
4. Wicker A. Getting out of our conceptual ruts: strategies for expanding conceptual frameworks. Am Psychologist 1985; 40: 1094-103.
5. Gottesman II, Shields J. A polygeneic theory of schizophrenia. Proc Nat Acad Sci 1967; 58: 199-205.
6. Richter T, Ronald P. The evolution of disease resistant genes. Plant Molecular Biology 2000; 42: 195-204.
7. Mackenzie K, Bishop S. Utilizing stochastic genetic epidemiological models to quantify the impact of selection for resistance to infectious disease in domestic livestock. Journal of Animal Science 2001; 79: 2057-65.
8. Kallmann FJ, Reisner D. Twin studies on the genetic variation in resistance to tuberculosis. J Heredity 1943; 34: 293-301.
9. Werneck-Barroso E. Innate resistance to tuberculosis: revisiting Max Lurie genetic experiments in rabbits. Int J Tuberculosis Lung Dis 1999; 3: 166-8.
10. McGue M, Gottesman II, Rao DC. The transmission of schizophrenia under a multifactorial threshold model. Am J Human Genet 1983; 35: 1161-78.
11. Bion JF, Brun-Buisson C. Introduction - infection and critical illness: genetic and environmental aspects of susceptibility and resistance. Intensive Care Med 2000; 26 Supplement 1: Sl-S2.
12. Burt RA. Genetics of host response to malaria. Int J Parasitology 1999; 29: 973-9.
13. Hawken RJ, Beattie CW, Schook LB. Resolving the genetics of resistance to infectious diseases. Rev Sci Technol 1998; 17: 17-25.
14. Hill AV. Genetics of infectious disease resistance. Curr Opin Genet Dev 1996; 6: 348-53.
15. Hill AV. Genetics and genomics of infectious disease susceptibility. Br Med Bull 1999; 55: 401-13.
16. Seymour RM. Some aspects of the coevolution of virulence and resistance in contact transmission processes with ecological constraints. IMA J Math Appl Med Biol 1995; 12: 83-136.
17. Kitagawa M, Aizawa S, Ikeda H, Hirokawa W. Establishment of a therapeutic model for retroviral infection using the genetic resistance mechanism of the host. Pathol Int 1996; 46: 719-25.
18. Cook GS, Hill AV. Genetics of susceptibility to heman infectious disease. Nature Rev Genet 2001; 2: 967-77.
19. Blackwell JM. Genetics and genomics of infectious disease susceptibility. Trends Mol Med 2001; 7: 521-6.
20. Knight J. Polymorphisms in tumor necrosis factor and other cytokines as risks for infectious disease and the septic shock syndrome. Curr Infec Dis Report 2001; 3: 427-39.
21. Beskow AH, Gyllensten UB. Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri. Int J Cancer 2000; 101: 526-31.
22. Wang FS. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol 2003; 9: 641-44.
23. Munk-Jorgensen P, Ewald H. Epidemiology in neurobiological research: exemplified by the infulenza-schizophrenia story. Br J Psychiatry 2001; 40: S30-2.
24. Rubenstein G. Schizophrenia, rheumatoid arthrits and natural disease resistance. Schizophr Res 1991; 25: 177-81.
25. Morris JA. Schizophrenia, bacterial toxins and the genetics of redundancy. Med Hypotheses 1966; 46: 362-6.
26. O’Reilly SL, Singh SM. Retroviruses and schizophrenia revisited. Am J Med Genet 1966; 67: 19-26.
27. Yolken RH, Torrey EF. Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev 1995; 8: 131-45.
28. Yolken RH, Karlsson H, Yee F, Torrey EF. Endogenous retroviruses and schizophrenia. Brain Res Rev 2000; 31:193-9.
29. Torrey EF, Miller J, Rawlings R, Yolken RH. Seasonality of births in schizophrenia and bipolar disorder: a review of the research. Schizophr Res 1997; 28: 1-38.
30. Davidson K, Bagley CR. Schizophrenia-like psychoses associated with organic disorders of the central nervous system: a review of the literature. In: Current Problems in Neuropsychiatry (Herrington RN, ed). British Journal of Psychiatry Special Publication No. 4. Ashford, UK: Headly Brothers, 1969:113-84.
31. Hess D. Cerebral lupus vasculopathy. Mechanisms and clinical relevance. Ann New York Acad Sci 1997; 823: 154-68.
32. Lass P, Koseda M, Romanowicz G et al. Cerebral blood flow in Sjogren’s syndrome using 99Tcm-HMPAO brain SPET. Nuclear Med Comm 2000; 21: 31-5.
33. Thomas A, O’Brien J, Davis S et al. Ischemic basis for deep white matter hyperintensities in major depression. Arch Gen Psychiatry 2002; 59: 785-92.
34. Honey GF, Bullmore, ET. Functional brain mapping of psychopathology.J Neurol Neurosurgery Psychiatry 2002; 72: 432-9.
35. Harder D, Zhang, C, Gebremedhin, D. Astrocyte function in matching blood flow to metabolic activity. News Physiol Sci 2002; 17: 27-31.
36. Yoder E. Modifications in astrocyte morphology and calcium signaling induced by brain capillary endothelial cell line. Glia 2002;38: 137-45.
37. Bacic F, Uematsu S, McCarron RM, Spatz M. Dopamine receptors linked to adenylate cyclase in human cerebromicrovascular endothelium. J Neurochemistry 1991; 57: 1774-80.
38. Favard CSA, Vigny A, Nguyen-Legros J. Ultrastructural evidence for a close relationship between dopamine cell precesses and blood capillary walls in Macaca monkey and rat retina. Brain Res 1990; 523: 127-33.
39. Moises HA, Zoega T, Gottesman II. The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry 2002; 2 (www.biomedcentraI.com/1471-244X/2/8).
40. Ziad K, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000; 157: 683-94.
41. Wang H, Ochani M, Amelia C et al. Nicotinic acetylcholine receptor a7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-8.
42. Touitou I. The spectrum of familial mediterranean fever (FMF) mutations. Eur J Human Genet 2001; 9: 473-83.
43. Scholl P. Periodic fever syndromes. Curr Opin Pediatrics 2000; 12: 563-6.
44. Ozen S. Vasculopathy, Bechets syndrome and familial mediterranean fever. Curr Opin Rheumatol 1999; 11: 393-8.
45. Tutar E, Akar N, Atalay S et al. Familial mediterranean fever gene (MEFV) mutations in patients with rheumatic heart disease. Heart 2002; 87: 568-9.
46. Veasy LG, Hill HR. Immunologic and clinical correlations in rheumatic fever and rheumatic heart disease. Pediatr Infect Dis J 1997; 16: 400-7.
47. Yegin O, Coskun M, Ertug H. Cytokines in acute rheumatic fever. Eur J Pediatrics 1997; 156: 24-9.
48. Moore D. Neuropsychiatrie aspects of Sydenham’s chorea. J Clin Psychiatry 1996; 57: 407-14.
49. Bottas A, Richer MA. Pediatric autoimmune neuropsychiatrie disorders associated with streptoccal infections (PANDAS). Pediatr Infect Dis J 2002; 21: 67-71.
50. Swedo S, Rapport J, Cheslow D et al. High prevalence of obsessive-compulsive symptoms in patients with Sydenham’s chorea. Am J Psychiatry 1989; 146: 246-9.
51. Swedo SE, Leonard HL, Kiessling LS. Speculations on antineuronal antibody-mediated neuropsychiatrie disorders of childhood. Pediatrics 1994; 93: 323-6.
52. Asbahr F, Negrao AB, Gentil V et al. Obsessive compulsive and related syndromes in children and adolescents with rheumatic fever with and without chorea: a prospective 6 month study. Am J Psychiatry 1998; 155: 1122-4.
53. Garvey MA, Swedo SE. PANDAS: the search for environmental triggers of pediatric neuropsychiatrie disorders. Lessons from rheumatic fever. J Child Neurol 1998; 13: 413-23.
54. Keeler WR, Bender L. A follow-up study of children with behavior disorders and Sydenham’s chorea. Am J Psychiatry 1952;169: 421-8.
55. Wilcox JA, Nasrallan H. Sydenahm’s chorea and psychopathology. Neuropsychobiol 1988; 19: 6-8.
56. Guttmann E. On some constitutional aspects of chorea and on its sequelae. J Neurol Psychopathol 1936; 17: 16-26.
57. Van Der Horst L. Rheumatism and psychosis. Poli Psychiatrica Neurologica et Neurochirugica Neerlandica 1948; 1/2: 56-64.
58. Winkelman N, Eckel JL. The brain in acute rheumatic fever. Arch Neurol Psychiatry 1932; 28: 844-70.
59. Dublin W. Pathologic lesions of the brain associated with chronic rheumatic endocarditis and accompanied by psychosis. Dis Nerv System 1941; 2: 390-3.
60. Bruetsch W. The histopathology of the psychoses with subacute bacterial and chronic verrucose rheumatic endocarditis. Am J Psychiatry 1938; 95: 335-46.
61. Bruetsch W. Chronic rheumatic brain disease as a possible factor in the causation of some cases of dementia paraecox. Am J Psychiatry 1940; 97: 276-96.
62. Bruetsch W. Rheumatic enderitis of cerebral vessels: sequelae of rheumatic fever. Transac Am Neurol Assoc 1942; 68: 17-20.
63. Van Der Horst L. Rheuma und psychose. Arxhiv fur Psychiatrie und Zierschrift Neurologic 1949; 181: 325-36.
64. Lewis A, Minski L. Chorea and psychosis. Lancet 1935; 228: 536-8.
65. Howie D. Some pathological findings in schizophrenics. Am J Psychiatry 1960; 117: 59-62.
66. Skvortsova E. Clinical neuropsychiatric changes during rheumatism. Klinicheskaia Meditsina 1956; 34: 32-5.
67. Hammes E. Psychoses associated with Sydenham’s chorea. JAMA 1922; 79: 804-7.
68. Bruetsch W. Late cerebral sequelae of rheumatic fever. Arch Internal Med 1944; 73: 972-82.
69. Wertheimer N. Rheumatic schizophrenia. Arch Gen Psychiatry 1961;4:579-96.
70. Wertheimer N. A psychiatric follow-up of children with rheumatic fever and other chronic diseases. J Chronic Dis 1963; 16: 223-37.
71. Wilcox JA, Nasrallah HA. Sydenham’s chorea and psychosis. Neuropsychobiol 1986; 15: 13-4.
72. Beadles C. On the degenerative lesions of the arterial system in the insane, with remarks upon the nature of the granular ependyma.J Mental Science 1895; 41: 32-50.
73. Neubuerger K. The brain in rheumatic fever. Dis Nervous System 1947; 8: 259-62.
74. Bompiani G, Benedetti E, Cecconi D. Arteriopathie cerebrali reumatiche. Archivo Itaaliano di Anatomi E. Istologia Pathologica 1954; 28:1-35.
75. Bender L. Psychiatric, neurologic and neuropathologic studies in disseminated alterative arteriolitis. Arch Neurol Psychiatry 1936; 36: 790-815.
76. Greenfield JG, Wolfson JM. The pathology of Sydenham’s chorea. Lancet 1922; 203: 603-6.
77. Bini L, Giovanni M. Uber den chronischen cerebralrheumatismus. Archiv fur Psychiatrie und Zeitschrift Neurologie 1952; 188:261-73.
78. Costero I. Reacción de la microglia en el cerebro de los reumáticos. Gaceta Medica De Mexico 1951; 81: 49-60.
79. Costero I. Cerebral lesions responsible for death of patients with active rheumatic fever. Arch Neurol Psychiatry 1949; 62: 48-72.
80. Sachs B. The pathology of rheumatic fever. Am Heart J 1926; 1: 750-72.
81. Shiokawa Y. Microcirculation in rheumatic fever. 3rd European Conference on Microcirculation 1964; 7: 547-51.
82. Montgomery H. Capillary fragility in rheumatic fever. US Navy Med Bull 1946; 46: 1708-10.
83. Merill JT. Regulation of the vasculature: clues from lupus. Curr Opin Rheumatol 2002; 14: 504-9.
84. Curtis CE, Iacono WG, Beiser M. Relationships between nailfoid plexus visibility and clinical, neuropsychological, and brain structural measures in schizophrenia. Biol Psychiatry 1999; 46: 102-9.
85. Vinogradov S, Gottesman II, Moisés HW, Nichol S. Negative association between schizophrenia and rheumatoid arthritis. Schizophr Bull 1991; 17: 669-78.
86. Stollerman GH. Rheumatic fever. Lancet 1997; 349: 935-42.
87. Hanson DR. Getting the bugs into our genetic theories of schizophrenia. In: Behavior Genetic Principals of Development, Personality, and Psychopathology (DiLalla L, ed). Washington DC: American Psychiatric Press, 2004: 205-16.